News

Abbott announced the U.S. launch and the first commercial uses of the new EnSite Precision™ cardiac mapping system and Advisor™ FL Circular Mapping Catheter, Sensor Enabled™ to map cardiac arrhythmias during ablation treatments. The first...

ARCA biopharma, Inc., a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted therapies for cardiovascular diseases, announced that the 150th patient has been randomized into GENETIC-AF, a...

Reacting to a critical shortage of electrophysiology (EP) lab technicians and nurses who treat heart arrhythmias, SpringBoard Healthcare in collaboration with Duke Heart Center has launched an online education program to prepare EP workers...

CardioFocus, Inc. announced the initial clinical evaluation of the HeartLight® Excalibur Balloon™, a next-generation technology designed for the treatment of atrial fibrillation (AF). The Excalibur Balloon leverages the proven universal...

SentreHEART, Inc. announced that it has completed the Stage I enrollment milestone in the aMAZE Trial. The Trial aims to assess improved outcomes when the LARIAT Suture Delivery System (LARIAT) is used to close the left atrial appendage (LAA)...

AtriCure, Inc., a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, announced preliminary financial results for the fourth quarter and full year 2016 and provided 2017 financial...

Abbott announced it has completed the acquisition of St. Jude Medical, Inc., establishing the company as a leader in the medical device arena. The transaction provides Abbott with expanded opportunities for future growth and is an important...

BIOTRONIK is launching a new series of single- and dual-chamber pacemakers in Japan ahead of its global launch. These devices feature both the company’s ProMRI® and BIOTRONIK Home Monitoring® technology. “The size reduction achieved with the...

St. Jude Medical, Inc., a global medical device company, announced FDA clearance of its EnSite Precision™ cardiac mapping system and Advisor™ FL Circular Mapping Catheter, Sensor Enabled™. The new EnSite Precision cardiac mapping system is...

Stereotaxis, Inc., a global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, announced the release of an interface between its remote magnetic navigation system for electrophysiology (EP) procedures and the...